Balance Therapeutics
San Bruno, California, United States
About Balance Therapeutics
Balance Therapeutics is an R&D company focused on developing therapeutics to address conditions of intellectual disability. Balance's pharmacological approach, based on technology licensed from Stanford University has demonstrated the promising potential to address cognitive deficits in animal models of Down syndrome and Alzheimer’s disease. Clinical trials for the company’s lead product are currently in progress for Down Syndrome. Balance Therapeutics is located in San Bruno, California, and has a wholly-owned subsidiary in Melbourne, Australia.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $21.2M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2015)
- Website: balance-therapeutics.comdefault.aspx
- Phone: (650) 741-9100
Industries & Categories
Developer Tools, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/balance-therapeutics-2576604 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.